GleamWall
中文EN

BUDZ WEED, INC.

Services-Commercial Physical & Biological Research · OTC · SEC CIK 1393772 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-49.2%
TTM EPS YoY-33.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-216.0%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets301.6%
Debt / equity—
Current ratio0.01x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.21x
Accruals ratio-170.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$0$0$0$0$0$0$0$0
Cost of revenue$0$0$0$0$0$0$0—
Gross profit$0$0$0$0$0$0$0—
SG&A expense$55,819$74,726$67,833$622,258$58,519$64,052$383,268$64,422
Operating income-$83,390-$90,911-$163,955-$726,874-$66,897-$94,045-$434,737-$127,462
Interest expense$13,629$13,221——$7,016$13,571$5,718-$4,493
Pretax income-$97,019-$104,132-$175,256-$750,188-$73,913-$107,616-$440,455-$133,224
Income tax$0$0$0$0$33$0$0$0
Net income-$97,019-$104,132-$175,256-$750,188-$73,946-$107,616-$440,455-$133,224
EBITDA-$77,966-$85,476-$158,333-$728,943-$58,712-$88,424-$429,115-$121,840
EPS (diluted)-0.00-0.00-0.00—-0.00-0.00-0.00—
Weighted avg. shares (diluted)148.45M148.31M147.51M—135.93M135.93M132.43M—
Balance sheet
Cash & equivalents$663$1,066$1,795$33,130$400$5,350$3,142$159,355
Current assets$19,683$7,631$12,365$47,705$10,933$18,482$35,658$189,891
PP&E, net$461,936$466,711$471,496$476,467$481,439$486,411$491,382$496,354
Intangibles$29,033$29,683$30,333$30,983$31,633——$33,583
Total assets$510,652$504,025$515,713$559,906$532,267$548,906$575,128$738,366
Current liabilities$1.54M$1.44M$1.35M$1.25M$1.05M$996,833$921,364$959,372
Total liabilities$1.54M$1.44M$1.35M$1.25M$1.05M$996,833$921,364$959,372
Shareholders' equity-$1.03M-$939,171-$837,527-$688,361-$519,079-$447,927-$346,236-$221,006
Shares outstanding148.53M148.31M148.31M148.53M135.93M135.93M135.93M125.43M
Cash flow statement
Operating cash flow-$40,403-$18,729-$57,737-$119,665-$4,952$1,319-$71,838-$136,370
Financing cash flow$40,000$18,000$29,200$152,403$0$2,000-$84,300$290,269
Depreciation & amortization$5,424$5,435$5,622-$2,069$8,185$5,621$5,622$5,622
Stock-based compensation$0$0$0$500,000$0$0$300,000—

Free plan shows the latest 8 periods; Pro shows all 46 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.